The BMP4-BMPR1A axis represses BRCA1 in mammary stem cells and contributes to tumor initiation.
Aho, S.; Perbet, M.; Treilleux, I.; Buisson, A.; Jeanpierre, S.; Delay, E.; Maguer-Satta, V.; Guyot, B.
Show abstract
Basal-like breast cancer (BLBC) is an aggressive subtype frequently characterized by homologous recombination deficiency (HRD) and BRCAness, even in the absence of BRCA1 mutations. Here, we identify the BMP4-BMPR1A signaling axis as a novel regulator of BRCA1 expression and a driver of BRCAness in non-transformed immature mammary cells. We observed that high BMPR1A expression is correlated with low BRCA1 levels and poor BLBC prognosis in patients. We show that exposure to BMP4 induces BRCA1 transcriptional repression via BMPR1A, promoting a basal differentiation and impairing homologous recombination. This results in increased sensitivity to PARP inhibitors (PARPi) and accumulation of genetically-unstable, immature cells. In addition, long-term BMP4 stimulation or BMPR1A overexpression induced transformation. Our findings uncover a mechanism by which the tumor microenvironment may contribute to BLBC initiation through BMP4-induced suppression of BRCA1, and highlight BMP signaling and the resulting BRCAness as a therapeutic vulnerability in wild-type BRCA1 BLBCs.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Protein profiling of breast carcinomas reveals expression of immune-suppressive factors and signatures relevant to patient outcome 94%
- HERC1 regulates breast cancer cells migration and invasion 94%
- PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer 94%
Similar papers in this journal
- Targeting LDHC dysregulates the cell cycle and improves sensitivity to cisplatin and olaparib 95%
- TPX2 expression promotes sensitivity to dasatinib in breast cancer by activating the YAP transcriptional signaling. 94%
- MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation 94%
Similar papers in this journal
- MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis 96%
- Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer 95%
- Oncogenic signaling inhibits c-FLIP expression and promotes cancer cell survival during ECM-detachment 95%